tm logo
QUOTIENT
Live/Pending
SUSPENSION LETTER - MAILED

mailed

on 21 Mar 2024

Last Applicant/ Owned by

55 Cambridge Parkway, Suite 800E

Cambridge

MA

02142

Serial Number

98278615 filed on 20th Nov 2023

Registration Number

N/A

Correspondent Address

Christina M. Licursi

Christina M. Licursi WOLF, GREENFIELD & SACKS, P.C.

BOSTON, MA 02210-2206

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

QUOTIENT

Pharmaceutical preparations for the treatment and prevention of cancer, cardiovascular diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, genetic and genomic diseases and disorders, immunological diseases and disorders, metabolic diseases and disorders, endocrine diseases and disorders, kidney diseases and disorders, dermatological diseases and dis Read More

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations for the treatment and prevention of cancer, cardiovascular diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, genetic and genomic diseases and disorders, immunological diseases and disorders, metabolic diseases and disorders, endocrine diseases and disorders, kidney diseases and disorders, dermatological diseases and disorders, reproductive diseases and disorders, urological diseases and disorders, allergies, bone diseases and disorders, diseases and disorders of the musculo-skeletal and genitourinary systems, and viruses and infectious diseases; therapeutic pharmaceutical for the treatment and prevention of cancer, cardiovascular diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, genetic and genomic diseases and disorders, immunological diseases and disorders, metabolic diseases and disorders, endocrine diseases and disorders, kidney diseases and disorders, dermatological diseases and disorders, reproductive diseases and disorders, urological diseases and disorders, allergies, bone diseases and disorders, diseases and disorders of the musculo-skeletal and genitourinary systems, and viruses and infectious diseases; pharmaceutical compositions comprised of small molecules for the treatment and prevention of cancer, cardiovascular diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, genetic and genomic diseases and disorders, immunological diseases and disorders, metabolic diseases and disorders, endocrine diseases and disorders, kidney diseases and disorders, dermatological diseases and disorders, reproductive diseases and disorders, urological diseases and disorders, allergies, bone diseases and disorders, diseases and disorders of the musculo-skeletal and genitourinary systems, and viruses and infectious diseases; pharmaceutical preparations, namely, DNA therapeutics for the treatment and prevention of cancer, cardiovascular diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, genetic and genomic diseases and disorders, immunological diseases and disorders, metabolic diseases and disorders, endocrine diseases and disorders, kidney diseases and disorders, dermatological diseases and disorders, reproductive diseases and disorders, urological diseases and disorders, allergies, bone diseases and disorders, diseases and disorders of the musculo-skeletal and genitourinary systems, and viruses and infectious diseases; pharmaceutical preparations, namely, RNA therapeutics for the treatment and prevention of cancer, cardiovascular diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, genetic and genomic diseases and disorders, immunological diseases and disorders, metabolic diseases and disorders, endocrine diseases and disorders, kidney diseases and disorders, dermatological diseases and disorders, reproductive diseases and disorders, urological diseases and disorders, allergies, bone diseases and disorders, diseases and disorders of the musculo-skeletal and genitourinary systems, and viruses and infectious diseases


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 98278615

Mark Type

No Service/Collective Mark

Attorney Docket Number

No F09042000200

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
21st Mar 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
21st Mar 2024LETTER OF SUSPENSION E-MAILED
21st Mar 2024SUSPENSION LETTER WRITTEN
19th Mar 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
19th Mar 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
19th Mar 2024TEAS/EMAIL CORRESPONDENCE ENTERED
26th Feb 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
26th Feb 2024NON-FINAL ACTION E-MAILED
26th Feb 2024NON-FINAL ACTION WRITTEN
20th Feb 2024ASSIGNED TO EXAMINER